Search company, investor...
CU Medical Systems company logo

CU Medical Systems

Founded Year




Date of IPO


Market Cap


About CU Medical Systems

CU Medical Systems (KRX: 115480) is engaged in the development, manufacturing, and marketing of defibrillators and cardiac monitors for hospital, pre-hospital, alternative care, and public access defibrillation use.

Headquarters Location

130-1, Donghwagongdan-ro Munmak-eup, Wonju-si

Gangwon-do, 26365,

South Korea

+82 031-421-9700

Missing: CU Medical Systems's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CU Medical Systems's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing CU Medical Systems

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CU Medical Systems is included in 2 Expert Collections, including Medical Devices.


Medical Devices

8,553 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

CU Medical Systems Patents

CU Medical Systems has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Cardiac arrhythmia, Cardiac electrophysiology, Antiarrhythmic agents, Wave mechanics, Syndromes affecting the heart


Application Date


Grant Date



Related Topics

Cardiac arrhythmia, Cardiac electrophysiology, Antiarrhythmic agents, Wave mechanics, Syndromes affecting the heart



Latest CU Medical Systems News

Global Defibrillators Market | Share ,Trend, Growth Rate ,Application & Top Companies

Oct 20, 2021

CU Medical Systems The growth during this market is driven by the rising prevalence of target diseases, growing specialise in providing public-access defibrillators, and coaching and awareness programs on defibrillators. additionally, rising markets and also the development of S-ICDs and MRI-compatible ICDs and CRT-Ds are expected to supply growth opportunities for players within the market. The growing range of internal organ implant procedures and also the accessibility of reimbursements across developed markets square measure the main factors driving the expansion of this end-user section. In 2016, Boston Scientific signed an agreement in the form of partnership with Mayo Clinic to speed up the event of medical devices partnered whereby each organizations aim to share property rights to develop new medical technologies. Furthermore, defibrillators were found to be extraordinarily helpful in restorative fulminant asystole in COVID19 that additional pushed for the demand for defibrillators within the pandemic state of affairs. Timely corroborative rules and increasing adoption is additional anticipated to produce this market with a profitable growth platform within the next few years. Click here to get the short-term and long-term impact of COVID-19 on this Market: Key Insights & Findings: The implantable cardioverter defibrillators segment accounted for the largest share of the defibrillators market in 2019. Factors which act as a contributor for accounting larger share are the development of technologically advanced devices with extended longevity, rapid growth in the number of implant procedures, and increasing adoption of cardiac resynchronization therapy defibrillators. The external defibrillator segment is anticipated to show high paying growth over the forecast period. In addition, robot-assisted surgeries were the most promising segment in the market for AI in healthcare as of 2020. The hospitals, clinics, and cardiac centres segment accounted for the largest share of the global market in 2019. Hospital segment dominated the market growth. the public access market section is calculable to register the quickest CAGR of around eight.6% over the forecast amount attributable to the increasing installation of defibrillators at public places North America considered to be the larger share in the region segment in the market. Asia Pacific is expected to expand at the fastest CAGR over the forecast period. Buy latest study report : About Us QualiKet Research is a leading Market Research and Competitive Intelligence partner helping leaders across the world to develop robust strategy and stay ahead for evolution by providing actionable insights about ever changing market scenario, competition and customers. QualiKet Research is dedicated to enhancing the ability of faster decision making by providing timely and scalable intelligence. We use different intelligence tools to come up with evidence that showcases the threats and opportunities which helps our clients outperform their competition.

CU Medical Systems Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CU Medical Systems Rank

CU Medical Systems Frequently Asked Questions (FAQ)

  • When was CU Medical Systems founded?

    CU Medical Systems was founded in 2001.

  • Where is CU Medical Systems's headquarters?

    CU Medical Systems's headquarters is located at 130-1, Donghwagongdan-ro, Gangwon-do.

  • What is CU Medical Systems's latest funding round?

    CU Medical Systems's latest funding round is IPO.

  • Who are the investors of CU Medical Systems?

    Investors of CU Medical Systems include JAFCO Asia.

  • Who are CU Medical Systems's competitors?

    Competitors of CU Medical Systems include Breathe Technologies, Stealth Therapeutics, Byram Healthcare, Degania Medical, Heartsine and 12 more.

Compare CU Medical Systems to Competitors

Care Dynamix

Care Dynamix is a provider of cost-efficient, high quality onsite vaccination clinics at U.S. companies, schools and retail locations of every size.

Proxy Biomedical Logo
Proxy Biomedical

Proxy Biomedical, headquartered in Galway, Ireland, is engaged in the development and manufacturing of surgical products that apply synthetic biomaterials technology for tissue regeneration.

Smart Medical Group

Smart Medical Group is the headquarters of a group of medical supply companies. It has its own R&D and production activities and is represented worldwide by a network of distributors. The Smart Medical Group aims to manage direct sales forces in Spain and the United Kingdom. Read more Strives for commercial excellence by offering a product range that satisfies the client's needs.

Simplex Diabetic Supply

Simplex was founded in April 2007 to provide home delivery of medical supplies to help patients with diabetes.


The biomedical startup specializes in advanced biosynthetic dressings for treating wounds and burns. E. Aubrey Woodroof, a wound care specialist, founded Aubrey in 2007 to commercialize a dressing he had developed that has microscopic web-like interconnections and continuous pores throughout the dressing.


Quiescence Formerly QuoNova. Melbourne, develops healthcare products powered by safe technology to reduce the $30B costs of Healthcare Associated Infections HAIs) such as MRSA. Their business model is based on direct sale of a product suite to hospitals.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.